UNSPSC 51433800: Antihypertensive pyridazines

Antihypertensive drugs made from orthodiazines, compounds consistng of six-membered ring with two adjacent nitrogen atoms.

UNSPSC 51433800 Antihypertensive pyridazines is a Class code under which state and local governments procure emergency life-support medications and generic pharmaceutical products for distribution through emergency medical services, healthcare systems, and state pharmacy benefit programs. Recent solicitations show that the code captures a mix of direct medication purchases for acute-care use—specifically vasodilators and antiarrhythmic agents used in advanced life support protocols—alongside broader generic pharmaceutical supply agreements that include antihypertensive compounds as part of multi-source product catalogs. Issuing bodies span municipal fire and rescue departments, state health agencies managing pharmacy benefits, and cooperative purchasing alliances coordinating procurement across multiple jurisdictions. The City of Tampa's Purchasing Department and the Texas Health and Human Services Commission represent the two primary categories: direct-buy emergency medication procurements for operational use, and state-level strategic pharmaceutical sourcing initiatives designed to establish manufacturer relationships or optimize cost management across public-sector health systems.

Geographic activity clusters in the South and Midwest. The City of Tampa (Florida) posted an IFB for Advanced Life Support Medications in April 2026, with a response deadline of April 8, 2026, seeking 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials on a one-year contract with optional renewals and 5 percent SLBE bid preference, estimated value $40,000. Texas Health and Human Services Commission issued an RFI in March 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional PBM and GPO channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP in January 2026 with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products to be distributed across member state and local facilities in Minnesota and Oregon, using three authorized wholesalers and effective July 1, 2026. Cooperative purchasing vehicles and state pharmacy benefit consolidation appear to drive higher-dollar strategic procurements, while municipal emergency services sustain steady transactional demand for specific high-volume life-support agents.